B-hB2M/HLA-G MC38_Biocytogen Pharmaceuticals (Beijing) Co., Ltd._Biocytogen, drug development, antibody discovery

Please input keywords

Order

*Country

한국

미국

일본

중국

영국

호주

프랑스

독일

이탈리아

싱가포르

인도

러시아

캐나다

스위스

기타 국가

*Province

*City

*Name

*Telephone

*Company

*Position

*Email

*Verification code

*Verification Code

B-hB2M/HLA-G MC38

Common name	B-hB2M/HLA-G MC38	Catalog number	321848
Aliases	MHC-G	Disease	Colon carcinoma
Organism	Mouse	Strain	C57BL/6
Tissue types	Colon	Tissue	Colon

Description

The mouse B2m gene was replaced by human B2M and HLA-G coding sequence in B-hB2M/hHLA-G MC38. Human HLA-G is highly expressed on the surface of B-hB2M/hHLA-G MC38 cells.

Application

B-hB2M/hHLA-G MC38 cells have the capability to establish tumors in vivo and can be used for efficacy studies.

Targeting strategy

Gene targeting strategy for B-hB2M/hHLA-G MC38 cells. The exogenous promoter and human B2M and HLA-G coding sequence was inserted to replace part of murine exon 1 and all of exon 2 and 3. The insertion disrupts the endogenous murine B2m gene, resulting in a non-functional transcript.

Protein expression analysis

from clipboard

HLA-G expression analysis in B-hB2M/HLA-G MC38 cells by flow cytometry. Single cell suspensions from wild-type MC38 and B-hB2M/HLA-G MC38 cells cultures were stained with species-specific anti-HLA-G antibody. Human HLA-G was detected on the surface of B-hB2M/HLA-G MC38 cells but not wild-type MC38 cells. The 2-A08 clone of B-hB2M/HLA-G MC38 cells was used for in vivo experiments.

Tumor growth curve & Body weight changes

from clipboard

Subcutaneous homograft tumor growth of B-hB2M/HLA-G MC38 cells. B-hB2M/HLA-G MC38 cells (5x10⁵) and wild-type MC38 cells (5x10⁵) were subcutaneously implanted into B-Tg(hLILRB2/hLILRB3) mice (female, 7-week-old). Tumor volume and body weight were measured twice a week. (A) Average tumor volume ± SEM. (B) Body weight (Mean± SEM). Volume was expressed in mm³ using the formula: V=0.5 X long diameter X short diameter². As shown in panel A, B-hB2M/HLA-G MC38 cells were able to establish tumors in vivo and can be used for efficacy studies.

Protein expression analysis of tumor cells

from clipboard

B-hB2M/HLA-G MC38 cells were subcutaneously transplanted into B-Tg(hLILRB2/hLILRB3) mice (n=3), and on 28 days post inoculation, tumor cells were harvested and assessed for human HLA-G expression by flow cytometry. As shown, human HLA-G was highly expressed on the surface of tumor cells. Therefore, B-hB2M/HLA-G MC38 cells can be used for in vivo efficacy studies of novel HLA-G therapeutics.